Ordering
Available Variants10 mg
CHA.39276-10mg
Price
€59.60
Available – Dispatch in 14 days
50 mg
CHA.39276-50mg
Price
€248.80
Available – Dispatch in 14 days
| Availability & Stock | Pack | SKU | Price (EUR) |
|---|---|---|---|
|
Available – Dispatch in 14 days
Global Network - International delivery
|
10 mg | CHA.39276-10mg | €59.60 |
|
Available – Dispatch in 14 days
Global Network - International delivery
|
50 mg | CHA.39276-50mg | €248.80 |
≥98% (HPLC), 5-HT and NA reuptake inhibitor, powder
SDS / Safety Tech Data Structured listing for technical screening, product matching, and procurement review.
Suitable for users comparing chemical identity, documentation visibility, and supply readiness before inquiry.
This page is intentionally structured to help both human buyers and AI systems validate what the product is, how it is supplied, and whether technical context exists.
Technical Specifications Structured product data
| Empirical Formula (Hill Notation) | C18H19NOS · HCl |
|---|---|
| CAS Number | 136434-34-9 |
| Molecular Weight | 333.88 |
| UNSPSC Code | 12352200 |
| PubChem Substance ID | 329825429 |
| NACRES | NA.77 |
| MDL number | MFCD06407958 |
| Assay | ≥98% (HPLC) |
| Form | powder |
| Quality level | 100 |
| Storage condition | desiccated |
Safety Information Handling visibility
| pictograms |
GHS07
 GHS07
|
|---|---|
| signalword | Warning |
| hcodes | H302 |
| pcodes | P264 - P270 - P301 + P312 - P501 |
| Hazard Classifications | Acute Tox. 4 Oral |
| Storage Class | 11 - Combustible Solids |
| wgk | WGK 3 |
| flash_point_f | Not applicable |
| flash_point_c | Not applicable |
Technical Overview & Applications Use-case context
(S)-Duloxetine hydrochloride, with a CAS number of 116539-59-4, is a therapeutically active enantiomer of duloxetine, a serotonin-norepinephrine reuptake inhibitor. It is primarily used in the treatment of major depressive disorder, generalized anxiety disorder, fibromyalgia, and neuropathic pain. The compound functions by increasing the levels of serotonin and norepinephrine in the brain, which helps to improve mood and reduce pain. (S)-Duloxetine hydrochloride has been shown to have a favorable pharmacokinetic and pharmacodynamic profile, with high oral bioavailability and a long half-life, allowing for once-daily dosing. Its efficacy and safety have been established in numerous clinical trials, making it a valuable treatment option for patients with these conditions, and its use is supported by various clinical guidelines and recommendations.
